Natural Supplements to Ward Off Alzheimer’s (Aging on the Brain: The Neurodegenerative Battle)

References

1. Zhang, Laura et al. “Curcuminoids enhance amyloid-beta uptake by macrophages of Alzheimer's disease patients” J Alzheimers Dis. 2006;10(1):1-7
2. Pandey N et al. “Curcumin inhibits aggregation of alpha-synuclein” Acta Neuropathol. 2008;115(4):479-89
3. Ryu EK et al. “Curcumin and dehydrozingerone derivatives: synthesis, radiolabeling, and evaluation for beta-amyloid plaque imaging” J Med Chem. 2006;49(20):6111-9
4. Garcia-Alloza M et al. “Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model” J Neurochem. 2007;102(4):1095-104
5. Yang F et al. “Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo” J Biol Chem. 2005;280(7):5892-901
6. Freund-Levi Y et al. “Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial” Arch Neurol. 2006;63(10):1402-8
7. Lim, GP et al. “A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model” J Neurosci. 2005;25(12):3032-40
8. Ma QL et al. “Omega-3 fatty acid docosahexaenoic acid increases SorLA/LR11, a sorting protein with reduced expression in sporadic Alzheimer's disease (AD): relevance to AD prevention” Neurosci. 2007;27(52):14299-307
9. Hooijmans CR, “Changes in cerebral blood volume and amyloid pathology in aged Alzheimer APP/PS1 mice on a docosahexaenoic acid (DHA) diet or cholesterol enriched Typical Western Diet (TWD)” Neurobiol Dis. 2007;28(1):16-29
10. Arendash GW  et al. “A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer's transgenic mice” Neuroscience 2007;149(2):286-302
11. Gatti G et al. “A comparative study of free plasma choline levels following intramuscular administration of L-a-glycerylphosphorylcholine and citicoline in normal volunteers” Inter J Clin Pharmacol. 1992;30(9):331-35
12. Zhang NY et al. “Soybean-derived phosphatidylinositol inhibits in vivo low concentrations of amyloid beta protein-induced degeneration of hippocampal neurons in V337M human tau-expressing mice” Life Sci. 2007;80(21)1971-76
13. Cenacchi T et al. “Cognitive decline in the elderly: a double-blind, placebo-controlled multicenter study on efficacy of phosphatidylserine administration” Aging Clin Exp Res. 1993;5(2):123-33
14. Engel RR et al. “Double-blind cross-over study of phosphatidylserine vs. placebo in patients with early dementia of the Alzheimer type”Eur Neuropsychopharmacol. 1992;2(2):149-55
15. Puca FM et al. “Exploratory trial of phosphatidylserine efficacy in mildly demented subjects” Clin. Trials J. 1987;24:94-98
16. Z. Subhan et al. “Psychopharmacological effects of vinpocetine in normal healthy volunteers” Eur J Clin Pharmacol. 1985;28(5):567-71
17. Kim JH et al. “A three month placebo-controlled clinical trial of INM 176 in the old aged subjects with memory impairment” J Korean Neuropsychiatr Assoc. 2003;42(2):254-62
18. So Young Kang et al. “Decursin from Angelica gigas mitigates amnesia induced by scopolamine in mice” Neurobio Learn Mem. 2003(79):11-18
19. Ji-Jing Yan et al. “Protection against β-amyloid peptide-induced memory impairment with long-term administration of extract of Angelica gigas or decursinol in mice” Prog Neuro-Psychopharm Bio Psychi. 2004;28(1)25-30
20. So Young Kang et al. “Coumarins Isolated from Angelica gigas Inhibit Acetylcholinesterase: Structure-Activity Relationships” J Nat Prod. 2001;64(5)683-85
21. Loren DJ et al. “Maternal dietary supplementation with pomegranate juice is neuroprotective in an animal model of neonatal hypoxic-ischemic brain injury” Pediatr Res. 2005;57(6):858-64
22. Yang X et al. “Coenzyme Q10 attenuates beta-amyloid pathology in the aged transgenic mice with Alzheimer presenilin 1 mutation” J Mol Neurosci. 2008;34(2):165-71
23. Ono K et al. “Preformed beta-amyloid fibrils are destabilized by coenzyme Q10 in vitro” Biochem Biophys Res Commun. 2005;330(1):111-6
24. Lü JH, Guo J, Yang WH “Effects of green tea polyphenol on the behaviour of Alzheimer' s disease like mice induced by D-galactose and Abeta25-35” Zhong Yao Cai.2006;29(4):352-4
25. Haque AM et al. “Green tea catechins prevent cognitive deficits caused by Abeta(1-40) in rats” J Nutr Biochem. 2008 Feb 14 Epub ahead of print
26. Avramovich-Tirosh Y et al. “Neurorescue activity, APP regulation and amyloid-beta peptide reduction by novel multi-functional brain permeable iron- chelating- antioxidants, M-30 and green tea polyphenol, EGCG” Curr Alzheimer Res. 2007;4(4):403-11
27. Kim D et al. “SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis” EMBO J. 2007;26(13):3169-79 
28. Wang J et al. “Moderate consumption of Cabernet Sauvignon attenuates Abeta neuropathology in a mouse model of Alzheimer's disease” FASEB J. 2006;20(13):2313-20
29. Luo L, Huang YM “Effect of resveratrol on the cognitive ability of Alzheimeros mice” Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2006;31(4):566-9
30. Cannelly PJ et al. “A randomised double-blind placebo-controlled trial of folic acid supplementation of cholinesterase inhibitors in Alzheimer's disease.” Int J Geriatr Psychiatry. 2008;23(2):155-60.
31. Durga, Jane et al. “Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial” Lancet. 2008;369(9557):208-216
32. Tettamanti M et al. “Low folate and the risk of cognitive and functional deficits in the very old: the Monzino 80-plus study”J Am Coll Nutr. 2006;25(6):502-8
33. Wahlin A et al. “Vitamin B status and cognitive performance in preclinical and clinical Alzheimer's disease: data from the Kungsholmen Project” Dement Geriatr Cogn Disord. 2008;25(1):23-31
34. Sun Y et at. “Efficacy of multivitamin supplementation containing vitamins B6 and B12 and folic acid as adjunctive treatment with a cholinesterase inhibitor in Alzheimer's disease: a 26-week, randomized, double-blind, placebo-controlled study in Taiwanese patients” Clin Ther. 2007;29(10):2204-14
35. Alvarez XA et al. “Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion” Methods Find Exp Clin Pharmacol. 1999;21(9):633-44
36. Parnetti L et al. “Posatirelin for the treatment of late-onset Alzheimer's disease: a double-blind multicentre study vs citicoline and ascorbic acid” Acta Neurol Scand. 1995;92(2):135-40
37. Alvarez XA et al. “Citicoline improves memory performance in elderly subjects” Methods  Find Exp Clin Pharmacol. 1997;19(3):201-10
38. Mazza M et al. “Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo-controlled double-blind study” Eur J Neurol. 2006;13(9):981-5
39. The Effects of Ginkgo Biloba on Cognitive and Cerebral Metabolic Function in age-associated memory” 2003 Abstract Viewer/Itinerary Planner.Washington, DC: Society for Neuroscience, 2003. Online